Vanguard Group Inc Nexalin Technology, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 125,460 shares of NXL stock, worth $424,054. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,460
Previous 31,780
294.78%
Holding current value
$424,054
Previous $21,000
1542.86%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NXL
# of Institutions
22Shares Held
617KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA107KShares$362,4740.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny103KShares$347,8020.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il58.2KShares$196,6650.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE55.5KShares$187,4610.81% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA42.4KShares$143,2540.0% of portfolio
About Nexalin Technology, Inc.
- Ticker NXL
- Exchange
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 7,279,960
- Market Cap $24.6M